These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 9843254)

  • 21. Follow-up after intravitreal triamcinolone acetonide for exudative age-related macular degeneration.
    Jonas JB; Spandau UH; Kamppeter BA; Harder B
    Eye (Lond); 2007 Mar; 21(3):387-94. PubMed ID: 16410809
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Intravitreal triamcinolone acetonide for the treatment of intraocular edematous and neovascular diseases].
    Jonas JB; Kreissig I; Kamppeter B; Degenring RF
    Ophthalmologe; 2004 Feb; 101(2):113-20. PubMed ID: 14991306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prospective study of intravitreal triamcinolone acetonide versus bevacizumab for macular edema secondary to central retinal vein occlusion.
    Ding X; Li J; Hu X; Yu S; Pan J; Tang S
    Retina; 2011 May; 31(5):838-45. PubMed ID: 21293319
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Periocular triamcinolone and photodynamic therapy for subfoveal choroidal neovascularization in age-related macular degeneration.
    ; Gilson MM; Bressler NM; Jabs DA; Solomon SD; Thorne JE; Wilson DJ
    Ophthalmology; 2007 Sep; 114(9):1713-21. PubMed ID: 17822977
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.
    Arias L; Garcia-Arumi J; Ramon JM; Badia M; Rubio M; Pujol O
    Ophthalmology; 2006 Dec; 113(12):2243-50. PubMed ID: 16996600
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2003 Aug; 110(8):1517-25. PubMed ID: 12917166
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravitreal triamcinolone versus intravitreal bevacizumab in the treatment of exudative retinal detachment secondary to posterior uveal melanoma.
    Parrozzani R; Pilotto E; Dario A; Miglionico G; Midena E
    Am J Ophthalmol; 2013 Jan; 155(1):127-133.e2. PubMed ID: 22995029
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome of intravitreal triamcinolone in uveitis.
    Kok H; Lau C; Maycock N; McCluskey P; Lightman S
    Ophthalmology; 2005 Nov; 112(11):1916.e1-7. PubMed ID: 16171868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial.
    Gillies MC; Sutter FK; Simpson JM; Larsson J; Ali H; Zhu M
    Ophthalmology; 2006 Sep; 113(9):1533-8. PubMed ID: 16828501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Secondary elevated IOP and cataracts after high-dose intravitreal triamcinolone and photodynamic therapy to treat choroidal neovascularization.
    Ruiz-Moreno JM; Montero JA; Amat P; Lugo FL
    J Glaucoma; 2009 Jan; 18(1):69-72. PubMed ID: 19142138
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary intravitreal triamcinolone acetonide for diabetic massive macular hard exudates.
    Khairallah M; Zeghidi H; Ladjimi A; Yahia SB; Attia S; Zaouali S; Messaoud R
    Retina; 2005; 25(7):835-9. PubMed ID: 16205560
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occult with no classic choroidal neovascularization secondary to age-related macular degeneration treated by intravitreal triamcinolone and photodynamic therapy with verteporfin.
    Nicolò M; Ghiglione D; Lai S; Nasciuti F; Cicinelli S; Calabria G
    Retina; 2006 Jan; 26(1):58-64. PubMed ID: 16395140
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.
    Spaide RF; Sorenson J; Maranan L
    Ophthalmology; 2005 Feb; 112(2):301-4. PubMed ID: 15691567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cataract surgery combined with intravitreal injection of triamcinolone acetonide.
    Jonas JB; Kreissig I; Budde WM; Degenring RF
    Eur J Ophthalmol; 2005; 15(3):329-35. PubMed ID: 15945000
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Intravitreal cortisone injection for refractory diffuse diabetic macular edema.
    Er H; Yilmaz H
    Ophthalmologica; 2005; 219(6):394-400. PubMed ID: 16286802
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Photodynamic therapy and high-dose intravitreal triamcinolone to treat exudative age-related macular degeneration: 2-year outcome.
    Ruiz-Moreno JM; Montero JA; Zarbin MA
    Retina; 2007; 27(4):458-61. PubMed ID: 17420698
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intravitreal triamcinolone injection for chronic diabetic macular oedema with severe hard exudates.
    Avci R; Kaderli B
    Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):28-35. PubMed ID: 16034605
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Complications of intravitreal steroid injections.
    Reichle ML
    Optometry; 2005 Aug; 76(8):450-60. PubMed ID: 16150412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two-year results of intravitreal triamcinolone acetonide injection for the treatment of diabetic macular edema.
    Batioğlu F; Ozmert E; Parmak N; Celik S
    Int Ophthalmol; 2007 Oct; 27(5):299-306. PubMed ID: 17453151
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary ocular hypertension after intravitreal injection of 4 mg of triamcinolone acetonide: incidence and risk factors.
    Vasconcelos-Santos DV; Nehemy PG; Schachat AP; Nehemy MB
    Retina; 2008 Apr; 28(4):573-80. PubMed ID: 18398360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.